Results 121 to 130 of about 540,422 (257)

Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. [PDF]

Clin Transl Allergy, 2023
Asllani J, Mitsias D, Konstantinou G, Mesonjesi E, Xhixha F, Shehu E, Christoff G, Noleva K, Makris M, Aggelidis X, Turkalj M, Damir E, Agache I, Tomic-Spiric V, Stosovic R, Misirligil Z, Kosnik M, Popov TA, Calderon M, Papadopoulos NG, ADER study group.   +20 more
europepmc   +1 more source

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah, Sangmee S. Bae, Tiffany De Leon, Yuna Lee, Rong Guo, David Elashoff, Jennifer Wang, Ani Shahbazian, Christina Charles‐Schoeman   +8 more
wiley   +1 more source

Australasian Society of Clinical Immunology and Allergy consensus statement on IEI molecular diagnosis. [PDF]

J Hum Immun
Yanes T, Cole T, Kane A, King J, Pinzon-Charry A, Hsiao KC, McNaughton P.   +6 more
europepmc   +1 more source

Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey. [PDF]

Clin Transl Allergy, 2022
Alvaro-Lozano M, Sandoval-Ruballos M, Giovannini M, Jensen-Jarolim E, Sahiner U, Tomic Spiric V, Quecchia C, Chaker A, Heffler E, Klimek L, Brough H, Sturm G, Untersmayr E, Bonini M, Pfaar O.   +14 more
europepmc   +1 more source

Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity

Arthritis Care &Research, EarlyView.
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley   +1 more source

Summarizing the 2024 immunotherapy manual of the Canadian society of allergy and clinical immunology. [PDF]

Allergy Asthma Clin Immunol
Bruton Joe A, Cai G, Nazarali S, Kim H, Lam G, Waserman S.   +5 more
europepmc   +1 more source

Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species. [PDF]

Int J Mol Sci, 2021
Zanna MY, Yasmin AR, Omar AR, Arshad SS, Mariatulqabtiah AR, Nur-Fazila SH, Mahiza MIN.   +6 more
europepmc   +1 more source

New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available on the development of fibromyalgia after exposure to high‐magnitude stress.
Jay B. Higgs, Willie J. Hale, Casey L. Straud, Jim Mintz, Stacey Young‐McCaughan, Kimberly D. Gomes, Chelsea J. Sterne, Katrina M. Lawrence‐Wolff, Alan J. Bartholomew, Kevin M. Kelly, Douglas M. Maurer, Catherine Vriend, Brett T. Litz, Douglas E. Williamson, Alan L. Peterson, for the STRONG STAR Consortium   +15 more
wiley   +1 more source

'What' and 'How' to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes. [PDF]

Clin Exp Allergy
Demidova A, Kiknavelidze N, Purtskhvanidze K, Alieva E, Ebrahimnejad M, Konchina S, Nurmeeva A, Matkovskii I, Elmurzaeva E, Davtian S, Degtyareva N, Drewitz KP, Asmanov A, Banjanin N, Botjes E, Comberiati P, Costa J, Chu DK, Epstein MM, Fedorova L, Galvin AD, Giovannini M, Greenhawt M, Jamalyan KR, Jones CJ, Khaleva E, Knibb RC, Leshem YA, Mack DP, Mafra I, Marchisotto MJ, Mijakoski D, Nurtazina A, Özdemir C, Peroni D, Protudjer JLP, Rodríguez del Río P, Schoos AM, Schopfer AF, Stoleski S, Upton J, van de Veen W, Genuneit J, Boyle RJ, Apfelbacher C, Munblit D.   +45 more
europepmc   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source